New arthritis drug shows promise in Long-Term safety trial
NCT ID NCT07223138
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at the long-term safety and effectiveness of a drug called sonelokimab for people with psoriatic arthritis. About 1560 adults who finished an earlier study will receive the drug as a shot under the skin. Researchers will track side effects and how well the drug controls arthritis symptoms over time.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ARTHRITIS, PSORIATIC are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinical Site
Avondale, Arizona, 85392, United States
-
Clinical Site
Mesa, Arizona, 85210, United States
-
Clinical Site
Phoenix, Arizona, 85032, United States
-
Clinical Site
Tucson, Arizona, 85748, United States
-
Clinical Site
Jonesboro, Arkansas, 72401, United States
-
Clinical Site
Upland, California, 91786, United States
-
Clinical Site
Avon Park, Florida, 33825, United States
-
Clinical Site
Clearwater, Florida, 33765, United States
-
Clinical Site
Tampa, Florida, 33607, United States
-
Clinical Site
Charlotte, North Carolina, 28262, United States
-
Clinical Site
Leland, North Carolina, 28451, United States
-
Clinical Site
Middleburg Heights, Ohio, 44130, United States
-
Clinical Site
Duncansville, Pennsylvania, 16635, United States
-
Clinical Site
Memphis, Tennessee, 38119, United States
-
Clinical Site
Baytown, Texas, 77521, United States
-
Clinical Site
Lubbock, Texas, 79424, United States